ArticleScientific reports2025
Rising burden of myopia among South Korean young adults based on 13-year trends, associated factors, and projections to 2050.
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed, 1 synthesis or guideline pooled it.
- Biological mechanisms of atropine in myopia control (Review).Molecular medicine reports · 2026Pooled it
- Thoracic angle of trunk rotation and its association with myopia among schoolchildren in a rural county of northeastern China.Frontiers in public health · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
To investigate long-term and projected trends of myopia and high myopia among young South Korean males and to evaluate associated sociodemographic risk factors. A repeated cross-sectional analysis was conducted using medical records from 4,063,091 19-year-old conscripts between 2011 and 2023. Logistic regression identified myopia risk factors, while linear regression assessed temporal trends. Projection modeling estimated future prevalence through 2050. Myopia prevalence increased from 50.6% in 2011 to 59.8% in 2023, and high myopia from 14.3% to 17.7%. Higher education was strongly associated with both conditions (P < 0.001), yet the gap narrowed. In 2011, odds of myopia and high myopia were over threefold higher in the most educated versus least educated groups (OR = 3.20 and OR = 3.03), but by 2023 had declined to approximately twofold (OR = 2.00 and OR = 1.99). Urban residents consistently showed higher risk compared with rural dwellers (P < 0.001), though disparities also narrowed (high myopia OR = 1.52 in 2011 vs. OR = 1.37 in 2023). Body stature indicators showed no consistent associations. Projection models suggested prevalence may reach 84% for myopia and 28% for high myopia by 2050. In this nationwide study, myopia and high myopia rose substantially over 13 years with narrowing sociodemographic disparities. Projections indicate further escalation, underscoring the urgent need for national prevention strategies.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.